Skip to Main Content
Services Talent Knowledge
Site Search
Menu

News

January 30, 2023

The Advocate: "What's the Hub-Bub?: Improved Efficiencies Could Be Costly to Pharmacies Not Conducting Due Diligence"

Linda Clark, Health Care Controversies team leader, had her “What’s the Hub-Bub?: Improved Efficiencies Could Be Costly to Pharmacies Not Conducting Due Diligence” article published in the National Association of Specialty Pharmacy’s member newsletter, the Advocate. The article explored the integral nature of hub service providers for the delivery of patients’ specialty medication. 

Linda article provided a brief history on hubs, foundational elements of hub models, and services hubs provide, among other key information. She also advised, “Pharmacies seeking to do business with hubs need to carefully assess whether the services being provided by the hub comply with legal and contractual requirements.” Linda continued, “In sum, hubs may streamline services and improve patient experience; however, pharmacies should not blindly be entering agreements that contain terms that result in violations of law, breaches of other contractual agreements, or do not make economic sense.”

Click here to read the full article.
 

Subscribe

Click here to sign up for alerts, blog posts, and firm news.

Featured Media

Alerts

California's Updated Privacy Regulations: Automated Decisionmaking Technology, Cybersecurity Audits, and Risk Assessments, Part 1

Alerts

Pharmacies on High Alert: Optum Rx's 25-Percent Therapeutic-Class Cap Creates Major Legal, Operational, and Competitive Risks

Alerts

New York State Clarifies Property Taxation of Wind and Solar Projects

Alerts

Website Accessibility Lawsuits: Several "Tester" Plaintiffs—Michael Mitchell, Edelmira Guerrero, Ana Jimenez, Dustin Youngren, William O'Donnell, Sophia Faldonie, and Kathy Wu—Targeting Businesses in Recent Flurry of Lawsuits

Alerts

New York State Now Requires Public Bidders to Implement Protections Against Gender-Based Violence in the Workplace

Alerts

Successor Liability: The Catch Behind "Free and Clear" in Bankruptcy Sales